Target intelligence / Profile preview

Perforin–granzyme–Fas ligand apoptotic pathway

Molecular classification
Other (multi-protein, multi-ligand pathway)
01

Overview

The perforin–granzyme–Fas ligand apoptotic pathway comprises the primary cytotoxic mechanisms used by activated cytotoxic T lymphocytes (CTLs) and NKT(-like) lymphocytes to induce apoptosis of target cells. These mechanisms include the granule exocytosis pathway, in which perforin, a pore-forming protein, facilitates the entry of serine proteases called granzymes (particularly granzyme B) into target cell cytosol, thereby cleaving key substrates to activate apoptotic cascades, including direct caspase activation and mitochondrial disruption. Separately, Fas ligand (FasL) on T/NKT cells binds to Fas receptor on target cells, triggering the formation of the death-inducing signaling complex (DISC) and activation of caspases. Both routes converge on apoptotic executioner mechanisms to eliminate virus-infected, tumor, or otherwise dangerous cells. The pathway does not represent a single molecular target but rather a convergence of several effector mechanisms characteristic of cytotoxic lymphocytes.

Other names
Perforin/granzyme pathwayGranule exocytosis pathwayDeath receptor pathwayFas ligand pathwayCTL/NK cell cytotoxicity mechanisms
02

Mechanism of action

Induction of apoptosis via: - Perforin-dependent delivery of granzymes into target cells - Fas ligand–Fas receptor interaction triggering caspase activation

03

Biological functions

ApoptosisImmune responseCell deathElimination of virus-infected cellsTumor surveillance
04

Disease associations

CancerInfectionAutoimmune disease (e.g., type 1 diabetes)Transplant rejection
05

Safety considerations

Off-target cytotoxicity and tissue damagePotential for autoimmunity or immunopathology if misregulated

Beyond the preview

Go deeper on Perforin–granzyme–Fas ligand apoptotic pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perforin–granzyme–Fas ligand apoptotic pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call